Industry wary over government’s new pharma policyPost published:August 21, 2017Post category:Industry NewsThe current draft pharma policy may have a negative impact on growth and profitability of the industry due to continued emphasis on price control, say industry officials and analysts Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostIndian Oil and Odisha government settle tax dispute Next PostRosneft closes $13-billion Essar Oil acquisition deal You Might Also Like E+E Elektronik announces EE820 sensor April 18, 2019 Aerojet Rocketdyne Acquires 3D Material Technologies and Expands Metal Additive Manufacturing Capabilities April 5, 2019 Record low inflation, slow IIP growth put focus on RBI for rate cut July 13, 2017
Aerojet Rocketdyne Acquires 3D Material Technologies and Expands Metal Additive Manufacturing Capabilities April 5, 2019